Impact of body mass index (BMI) on treatment outcomes to immune checkpoint blockade (ICB) in metastatic renal cell carcinoma (mRCC).
暂无分享,去创建一个
T. Choueiri | B. McGregor | L. Harshman | A. Lalani | R. Flippot | W. Xie | D. Heng | J. Steinharter | Aly-Khan A. Lalani